Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.43 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.43 |
| ▸ | PAM | P19021 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | MMP12 | P39900 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10011974 | 0.98 | DGKA (0.47) | DGKAGSTP1PAMCYP1A2MMP1 | |
| SCHEMBL10009668 | 0.95 | TSHR (0.42) | DGKAGSTP1PAMCYP1A2MMP1 | |
| SCHEMBL10011358 | 0.92 | TSHR (0.45) | GSTP1PAMTSHRLMNAALDH1A1 | |
| SCHEMBL2325380 | 0.91 | MMP1 (0.40) | DGKAGSTP1CYP1A2MMP1MMP2 | |
| SCHEMBL28372049 | 0.90 | DGKA (0.60) | DGKAPAMTSHRMAPTLMNA | |
| SCHEMBL11748323 | 0.90 | DGKA (0.60) | DGKAPAMTSHRMAPTLMNA | |
| SCHEMBL28370990 | 0.90 | DGKA (0.60) | DGKAPAMTSHRMAPTLMNA | |
| SCHEMBL10011979 | 0.90 | PAM (0.46) | PAMTSHRLMNAALDH1A1TDP1 | |
| SCHEMBL2341660 | 0.90 | DGKA (0.48) | DGKAPAMCYP1A2TSHRMAPT | |
| SCHEMBL9567418 | 0.88 | GSTP1 (0.36) | DGKAGSTP1PAMCYP1A2MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3156461-B1 | UV CURABLE INKJET INKS | AGFA NV (BE) | 2020-04-01 | — | — | EP | disclosed |
| US-10513620-B2 | UV curable inkjet inks | AGFA NV (BE) | 2019-12-24 | — | — | US | disclosed |
| US-20190071578-A1 | UV CURABLE INKJET INKS | AGFA NV (BE) | 2019-03-07 | — | — | US | disclosed |
| EP-3156462-A1 | UV CURABLE INKJET INKS | AGFA GRAPHICS NV (BE) | 2017-04-19 | — | — | EP | disclosed |
| EP-3156461-A1 | UV CURABLE INKJET INKS | AGFA GRAPHICS NV (BE) | 2017-04-19 | — | — | EP | disclosed |
| EP-3156463-A1 | UV CURABLE INKJET INKS | AGFA GRAPHICS NV (BE) | 2017-04-19 | — | — | EP | disclosed |
| EP-2464635-B1 | COPPER CATALYZED CYCLOADDITION OF ORGANIC AZIDES AND 1-HALOALKYNES | SCRIPPS RESEARCH INST (US) | 2015-09-16 | — | — | EP | disclosed |
| US-9130244-B2 | Nonaqueous electrolyte solution and electrochemical element using same | UBE INDUSTRIES, LTD. (JP) | 2015-09-08 | — | — | US | disclosed |
| EP-2908376-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | Ube Industries, Ltd. (JP) | 2015-08-19 | — | — | EP | disclosed |
| US-8927736-B2 | Copper catalyzed cycloaddition of organic azides and 1-haloalkynes | THE SCRIPPS RESEARCH INSTITUTE (US) | 2015-01-06 | — | — | US | disclosed |
| EP-2479831-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | Ube Industries, Ltd. (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120171581-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | UBE INDUSTRIES, LTD. (JP) | 2012-07-05 | — | — | US | disclosed |
| US-20120142935-A1 | COPPER CATALYZED CYCLOADDITION OF ORGANIC AZIDES AND 1-HALOALKYNES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120142935-A1 | COPPER CATALYZED CYCLOADDITION OF ORGANIC AZIDES AND 1-HALOALKYNES | AOC3, AOC2, CBR3 | DGKA 3038/4885GSTP1 4301/4885PAM 1304/4885 |
| US-20120171581-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | SLC8A1, OR10J3, SLC8B1 | DGKA 1127/4885GSTP1 3928/4885PAM 2577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.